Literature DB >> 30108722

Cancer nanomedicine: from PDGF targeted drug delivery.

Chandrababu Rejeeth1, Raju Vivek1, Varukattu NipunBabu2, Alok Sharma1, Xianting Ding1, Kun Qian1.   

Abstract

An innovative approach for the distinctively efficient action of smart targeted drug delivery to a specific cell type is obtained through the modification of the surface of nanoparticles. Specifically, the work identifies a cell surface receptor targeting drug delivery nanosystem based on mesoporous silica loaded with the anticancer drug cisplatin (cis-DDP) and poly-acrylic acid (PAA). A specific target is the PDGF receptors expressed in cervical cancer cells, thus making the PAA functionalized nanocomposite a suitable and promising nano-medicine for the targeting of PDGF-overexpressing cancers in the near future.

Entities:  

Year:  2017        PMID： 30108722      PMCID： PMC6071817          DOI： 10.1039/c7md00391a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN： 2040-2503            Impact factor:   3.597


  20 in total

Review 1.  Endocytic mechanisms for targeted drug delivery.

Authors:  Lisa M Bareford; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

2.  Cellular uptake of densely packed polymer coatings on gold nanoparticles.

Authors:  Mingtao Liang; I-Chun Lin; Michael R Whittaker; Rodney F Minchin; Michael J Monteiro; Istvan Toth
Journal:  ACS Nano       Date:  2010-01-26       Impact factor: 15.881

3.  Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance.

Authors:  Wei Zhang; Jianliang Shen; Hua Su; Ge Mu; Jing-Hua Sun; Cai-Ping Tan; Xing-Jie Liang; Liang-Nian Ji; Zong-Wan Mao
Journal:  ACS Appl Mater Interfaces       Date:  2016-05-17       Impact factor: 9.229

4.  Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB.

Authors:  Silvia Minardi; Laura Pandolfi; Francesca Taraballi; Xin Wang; Enrica De Rosa; Zachary D Mills; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  ACS Appl Mater Interfaces       Date:  2017-04-18       Impact factor: 9.229

5.  Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen.

Authors:  Zhou J Deng; Mingtao Liang; Istvan Toth; Michael J Monteiro; Rodney F Minchin
Journal:  ACS Nano       Date:  2012-09-25       Impact factor: 15.881

6.  Nanoceria-Mediated Drug Delivery for Targeted Photodynamic Therapy on Drug-Resistant Breast Cancer.

Authors:  Hong Li; Cong Liu; Yi-Ping Zeng; Yu-Hui Hao; Jia-Wei Huang; Zhang-You Yang; Rong Li
Journal:  ACS Appl Mater Interfaces       Date:  2016-11-11       Impact factor: 9.229

Review 7.  Receptor-targeted nanocarriers for therapeutic delivery to cancer.

Authors:  Bo Yu; Heng Chiat Tai; Weiming Xue; L James Lee; Robert J Lee
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

8.  Cisplatin-functionalized silica nanoparticles for cancer chemotherapy.

Authors:  Chandrababu Rejeeth; Tapas C Nag; Soundarapandian Kannan
Journal:  Cancer Nanotechnol       Date:  2013-07-20

9.  Plasmonic silver nanoshells for drug and metabolite detection.

Authors:  Lin Huang; Jingjing Wan; Xiang Wei; Yu Liu; Jingyi Huang; Xuming Sun; Ru Zhang; Deepanjali D Gurav; Vadanasundari Vedarethinam; Yan Li; Ruoping Chen; Kun Qian
Journal:  Nat Commun       Date:  2017-08-09       Impact factor: 14.919

Review 10.  Endocytosis unplugged: multiple ways to enter the cell.

Authors:  Sudha Kumari; Swetha Mg; Satyajit Mayor
Journal:  Cell Res       Date:  2010-02-02       Impact factor: 25.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.